SCHEMBL23920380

SCHEMBL23920380

O=C(NC1CCC(NC(=O)C2Cc3ccncc3O2)CC1)c1nc2cc(Cl)ccc2s1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAOB P27338 4/20 0.41
▸ GLS O94925 2/20 0.39
▸ CYP3A4 P08684 3/20 0.38
▸ CYP1A2 P05177 2/20 0.38
▸ CYP2C9 P11712 2/20 0.38
▸ CYP2C19 P33261 2/20 0.38
▸ AOC3 Q16853 1/20 0.38
▸ MAOA P21397 1/20 0.37
▸ NPC1 O15118 2/20 0.37
▸ RAB9A P51151 2/20 0.37
▸ CCNC P24863 1/20 0.37
▸ CDK8 P49336 1/20 0.37
▸ SMYD3 Q9H7B4 1/20 0.37
▸ F10 P00742 1/20 0.37
▸ TGFBR1 P36897 1/20 0.36
▸ LIPG Q9Y5X9 1/20 0.36
▸ SCN3A Q9NY46 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.35
▸ CYP2D6 P10635 1/20 0.35
▸ CNR2 P34972 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23920469 0.88 GLS (0.50) MAOBGLSCYP3A4CYP1A2CYP2C9
SCHEMBL23920267 0.81 ATF4 (0.42) GLSCYP3A4CYP1A2CYP2C9CYP2C19
SCHEMBL23920263 0.81 GLS (0.51) GLSCYP3A4CYP1A2CYP2C9CYP2C19
SCHEMBL23920375 0.79 HRH4 (0.42) CYP3A4CYP1A2CYP2C9CYP2C19AOC3
SCHEMBL23920219 0.79 CHRNA7 (0.47) CYP3A4CYP1A2CYP2C9CYP2C19NPC1
SCHEMBL23920262 0.75 HDAC1 (0.38) GLSCYP3A4CYP1A2CYP2C9CYP2C19
SCHEMBL22580427 0.70 CNR2 (0.58) MAOBMAOANPC1RAB9ASMYD3
SCHEMBL23996221 0.70 MAOB (0.49) MAOBMAOANPC1RAB9ASMYD3
SCHEMBL23920477 0.70 POLB (0.49) MAOBMAOANPC1RAB9ASMYD3
SCHEMBL23920621 0.69 KMT2A (0.58) GLSCYP3A4CYP1A2CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230047589-A1 INHIBITORS OF INTEGRATED STRESS RESPONSE PATHWAY ALTOS LABS, INC. 2023-02-16 — — US disclosed
US-11230542-B2 Inhibitors of integrated stress response pathway Praxis Biotech LLC (US) 2022-01-25 — — US disclosed
US-20210317102-A1 INHIBITORS OF INTEGRATED STRESS RESPONSE PATHWAY ALTOS LABS, INC. 2021-10-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210317102-A1 INHIBITORS OF INTEGRATED STRESS RESPONSE PATHWAY ATF4, DDIT3, ATF1 MAOB 2567/4885GLS 319/4885CYP3A4 4341/4885
US-11230542-B2 Inhibitors of integrated stress response pathway ATF4, DDIT3, ATF1 MAOB 2567/4885GLS 319/4885CYP3A4 4341/4885
US-20230047589-A1 INHIBITORS OF INTEGRATED STRESS RESPONSE PATHWAY ATF4, DDIT3, ATF1 MAOB 2567/4885GLS 319/4885CYP3A4 4341/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback